Quick Overview: Dr. Hawkes reviews the non-plaque variants of Chair, April W. Armstrong, MD, MPH, discusses Please join us for our next IDF Educational Series Webinar: The Innovation of a

Psoriasis And Beyond Targeting The - Detailed Overview & Context

Dr. Hawkes reviews the non-plaque variants of Chair, April W. Armstrong, MD, MPH, discusses Please join us for our next IDF Educational Series Webinar: The Innovation of a Professor Jonathan Barker explains the role of genetics in more accurately treating In our first SkinSideOut webinar, panel guests, Caroline Irwin ( Discover how TYK2 (Tyrosine Kinase 2) is revolutionizing autoimmune disease treatment in this in-depth, science-backed ...

Dr. Wiebke Ludwig-Peitsch from the Vivantes Clinic in Friedrichshain, Berlin talks about new developments in the treatment of ... It was not long ago that patients diagnosed with plaque

Photo Gallery

Psoriasis and beyond: targeting the IL-17 pathway
Psoriasis: The Surprising Link To Your Immune System
Beyond Plaque Psoriasis: Exploring Other Disease Variants | Jason Hawkes, MD, MS | United States
Psoriasis Treatment Breakthroughs | Dr. Chris Griffiths
Targeting the Burden of Moderate to Severe Psoriasis
Psoriasis Treatment Update: A Focus on Targeted Therapies
IDF Educational Series  The Innovation of a Targeted Oral Peptide in Moderate to Severe Plaque Psori
What role can genetics play in future psoriasis treatment? - Professor Jonathan Barker
Psoriasis: Taking control beyond your skin
New Hope For Psoriasis Patients
From Psoriasis to Lupus: How TYK2 Is Changing the Game
IL-23s: Psoriasis therapy overview
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored